Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.35M 2.05M 1.88M 1.76M 3.33M 223M 3.38M 22.62M 8.79M 110M 8.81M 8.61M 378M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.35M 2.93M 2.69M 2.51M 4.75M 319M 4.82M 32.27M 12.54M 156M 12.56M 12.29M 540M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
04-16 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
02-19 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
25-10-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
25-10-06 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
25-09-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
25-09-21 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
25-04-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
25-01-21 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
25-01-06 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
24-12-26 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
24-11-26 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
24-11-25 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
24-10-21 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2024 CI
1 week+50.00%
3 months-40.00%
6 months-50.00%
Current year-40.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0002
0
5 years 0
Extreme 0.0002
0.01
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 70 2019-12-18
Treasurer 61 2024-05-05
Corporate Secretary 66 2019-12-18
Director TitleAgeSince
Director/Board Member 70 2019-12-18
Director/Board Member 66 2019-12-18
Director/Board Member 61 2024-05-05
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+50.00%-50.00%-40.00% 3.52M
+1.70%+6.89%+2.76%+7.65% 49.15B
+0.92%+6.21%+408.85%+607.44% 40.23B
+1.89%+11.06%+25.75%-7.89% 34.55B
+2.38%+8.10%+21.83%+66.94% 33.09B
+3.96%+6.07%+14.14%+37.68% 25.19B
+2.51%+4.94% - - 17.05B
+2.58%+7.24%+71.03%+132.17% 15.92B
+0.32%+1.58%+14.34%+19.26% 13.83B
-1.14%+7.52%+14.75%-30.83% 13.26B
Average +1.51%+8.43%+58.16%+88.05% 24.23B
Weighted average by Cap. +1.81%+6.31%+89.14%+131.73%

Financials

2024 2025
Net sales 249K 218K 200K 186K 353K 23.69M 359K 2.4M 933K 11.63M 934K 914K 40.15M 303K 265K 243K 227K 430K 28.85M 437K 2.92M 1.14M 14.17M 1.14M 1.11M 48.89M
Net income -651K -570K -523K -488K -925K -62.01M -939K -6.28M -2.44M -30.45M -2.45M -2.39M -105M -549K -480K -441K -411K -779K -52.25M -791K -5.29M -2.06M -25.66M -2.06M -2.02M -88.54M
Net Debt 939K 822K 754K 704K 1.33M 89.42M 1.35M 9.06M 3.52M 43.91M 3.53M 3.45M 152M 1M 875K 803K 750K 1.42M 95.24M 1.44M 9.65M 3.75M 46.77M 3.76M 3.67M 161M
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
26-07-02 US$0.000300 0.00% 1,460,000
26-07-01 US$0.000300 0.00% 18,338,589
26-06-30 US$0.000300 +20.00% 520,000
26-06-29 US$0.000250 0.00% 4,050,033
26-06-26 US$0.000250 +8.70% 5,566,717
  1. Stock Market
  2. Stocks
  3. CBIH Stock